- Home
- FFWM vs EYPT Comparison
FFWM vs EYPT Comparison
Compare FFWM & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFWM
- EYPT
- Stock Information
- Founded
- FFWM 1990
- EYPT 1987
- Country
- FFWM United States
- EYPT United States
- Employees
- FFWM N/A
- EYPT N/A
- Industry
- FFWM Major Banks
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- FFWM Finance
- EYPT Industrials
- Exchange
- FFWM Nasdaq
- EYPT Nasdaq
- Market Cap
- FFWM 378.0M
- EYPT 390.0M
- IPO Year
- FFWM 2014
- EYPT 2005
- Fundamental
- Price
- FFWM $5.16
- EYPT $7.24
- Analyst Decision
- FFWM Buy
- EYPT Strong Buy
- Analyst Count
- FFWM 4
- EYPT 8
- Target Price
- FFWM $7.25
- EYPT $24.29
- AVG Volume (30 Days)
- FFWM 630.3K
- EYPT 864.9K
- Earning Date
- FFWM 07-24-2025
- EYPT 05-07-2025
- Dividend Yield
- FFWM N/A
- EYPT N/A
- EPS Growth
- FFWM N/A
- EYPT N/A
- EPS
- FFWM N/A
- EYPT N/A
- Revenue
- FFWM $113,564,000.00
- EYPT $56,042,000.00
- Revenue This Year
- FFWM $181.02
- EYPT N/A
- Revenue Next Year
- FFWM $8.08
- EYPT N/A
- P/E Ratio
- FFWM N/A
- EYPT N/A
- Revenue Growth
- FFWM N/A
- EYPT 12.04
- 52 Week Low
- FFWM $4.42
- EYPT $3.91
- 52 Week High
- FFWM $8.52
- EYPT $13.99
- Technical
- Relative Strength Index (RSI)
- FFWM 48.47
- EYPT 64.35
- Support Level
- FFWM $5.07
- EYPT $5.46
- Resistance Level
- FFWM $5.40
- EYPT $7.44
- Average True Range (ATR)
- FFWM 0.17
- EYPT 0.53
- MACD
- FFWM -0.02
- EYPT 0.14
- Stochastic Oscillator
- FFWM 18.00
- EYPT 90.65
About FFWM First Foundation Inc.
First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.